|
|||||
|
|
Safety and tolerability of intensified,N‐terminal pro brain natriuretic peptide‐guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME‐CHF |
|
| Authors: | Sandra Sanders‐van Wijk Stefano Muzzarelli Michael Neuhaus Stephanie Kiencke Micha Maeder Werner Estlinbaum Daniel Tobler Kurt Mayer Paul Erne Matthias E. Pfisterer Hans‐Peter Brunner‐La Rocca for the TIME‐CHF investigators |
| Affiliation: | 1. Maastricht University Medical Center, CARIM, , Maastricht, The Netherlands;2. Universit?tsspital Basel, , Basel, Switzerland;3. Cardiocentro Ticino, , Lugano, Switzerland;4. Kantonsspital Baden, , Baden, Switzerland;5. Kantonsspital Bruderhol, , Bruderholz, Switzerland;6. Kantonsspital St. Gallen, , St. Gallen, Switzerland;7. Kantonsspital Liestal, , Liestal, Switzerland;8. Kantonsspital Graubünden, , Chur, Switzerland;9. Luzerner Kantonsspital, , Lucerne, Switzerland |
| Abstract: | |
| Keywords: | Heart failure Natriuretic peptide Safety Drug therapy Ageing Co‐morbidities |